Medical Device Industry News

UPDATE: FDA panel votes against Edap's ultrasound prostate cancer ablation

July 31, 2014 by Ingrid Mezo

An FDA advisory panel votes that French device maker Edap failed to demonstrate that its novel Ablatherm prostate cancer treatment is safe and effective.

UPDATE: FDA panel votes against Edap's ultrasound prostate cancer ablation

Baxter sheds vaccines biz for $635M

July 31, 2014 by Arezu Sarvestani

Illinois healthcare giant Baxter sells its commercial vaccines division ahead of a larger transformation that will split its medical products and pharmaceuticals businesses into separate entities.

`Baxter sheds vaccines biz for $635M

Baxter (NYSE:BAX) agreed to offload its commercial vaccines business to pharmaceutical rival Pfizer (NYSE:PFE) for $635 million in cash.

Report: Medtech M&A exits don't hinge on FDA approval

July 31, 2014 by Arezu Sarvestani

Medical device startups face significant headwinds in finding funding and getting to an exit, but at least prospective buyers are a little more willing to gamble on companies that haven't yet made it through the FDA.

Report: Medtech M&A no longer hinges on FDA approval

The funding environment for medical device startups isn't a pretty scene, but there is a ray of sunshine through the gloom: lack of FDA approval is no longer a deal-breaker for a big exit.

In 2013 a few medtech companies managed "big exit M&A" deals (those worth $50 million or more) without having reached the FDA's brass ring, according to a new report from Silicon Valley Bank.

MassDevice.com +3 | The top 3 medtech stories for July 31, 2014

July 31, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Report: Lantheus spikes IPO plans

July 31, 2014 by Brad Perriello

Lantheus Medical Imaging spikes plans for a $125 million initial public offering, citing 'poor market conditions.'

Report: Lantheus spikes IPO plans

Lantheus Medical Imaging reportedly spiked an initial public offering it hoped would raise $125 million, citing "poor market conditions," Renaissance Capital reported.

Strong Q2 can't buoy HeartWare as shares sink on recall news

July 31, 2014 by Brad Perriello

A voluntary recall initiated yesterday pushes HeartWare shares down today, despite 2nd-quarter result that crushed expectations on Wall Street.

Strong Q2 can't buoy HeartWare after recall news

UPDATED July 31, 2014 with additional comment on recall.

Smith & Nephew shifts jobs to China

July 31, 2014 by Arezu Sarvestani

Smith & Nephew confirms that it's cutting some of its U.K. manufacturing jobs and moving the positions to a plant in China.

Smith & Nephew shifts jobs to China
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp